Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARADIGM-HF/Entresto; the POLO trial, olaparib in pancreas cancer; and the paper "An algorithmic approach to reducing unexplained pain disparities in underserved populations".

CheckMate 274: doi.org/10.1056/NEJMoa2034442

PARADIGM-HF: doi.org/10.1056/nejmoa1409077

POLO: doi.org/10.1056/NEJMoa1903387

Knee pain: doi.org/10.1038/s41591-020-01192-7

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew